Acquisition / mergerNotable· Adverse for the businessFiled on BSE ·

Emami approves FY 2026 results, MD re-appointment pending vote, two acquisitions agreed

Emami · Personal Products

Arthneeti Research DeskPublished 1 min read
73.5%Acquisition / merger

Key highlights

  • Board approved audited standalone and consolidated FY 2026 results; standalone profit before tax ₹90,079 lacs, consolidated ₹84,607 lacs.
  • Board re-appointed Shri Harsha Vardhan Agarwal as Vice-Chairman & Managing Director for five years from 1 April 2027, subject to AGM shareholder approval.
  • Axiom Ayurveda: definitive agreement for remaining 73.5% stake, up to Rs.200 crores, subject to closing conditions. IncNut Digital: agreement for 60% stake, up to Rs. 321 crores.

Why it's rated notable: the year-on-year change is 12% (10% to 20% for adverse news)

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Change in Management

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Emami

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.